Key Point • RIC with early alemtuzumab preconditioning results in favorable outcomes in HLH following allogeneic hematopoietic cell transplantation. Click to show full abstract
Key Point • RIC with early alemtuzumab preconditioning results in favorable outcomes in HLH following allogeneic hematopoietic cell transplantation.
               
Click one of the above tabs to view related content.